Trial intelligence / Profile preview

Apatinib combined with capecitabine for advanced triple-negative breast cancer

ChiCTR1800018673Phase 4Recruiting

Sponsor

First Affiliated Hospital of Chongqing Medical University

Start

Oct 2018

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1